Health consumption and costs reduction in patients with ankylosing spondylitis (AS) treated with etanercept (ETA) for 2 years.

被引：0
|
作者：
Benhamou, Mathilde
Kolta, Sami
Briot, Karine
Roux, Christian
Dougados, Maxime
Fautrel, Bruno
机构：
[1] Univ Paris 05, Cochin Hosp, Dept Rheumatol, Paris, France
[2] Univ Paris 06, Pitie Salpetriere Hosp, Dept Rheumatol, Paris, France
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S718 / S719
页数：2
相关论文
共 50 条
  • [21] Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy
    Davis, JC
    Van der Heijde, D
    Dougados, M
    Woolley, JM
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (04): : 494 - 501
  • [22] Patient reported outcomes of improvement in patients with ankylosing spondylitis treated iwth etanercept for 148 to 160 weeks
    Dijkmans, B. A. C.
    Sieper, J.
    Van der Linden, S.
    Sibilia, J.
    Mola, E. Martin
    Leirisalo-Repo, M.
    Pedersen, R.
    Singh, A.
    Freundlich, B.
    MacPeek, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 432 - 432
  • [23] Outcome of patients with active ankylosing spondylitis after 2 years of therapy with etanercept - Clinical data supported by magnetic resonance imaging
    Baraliakos, X
    Rudwaleit, M
    Listing, J
    Brandt, J
    Haibel, H
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S632 - S633
  • [24] No difference in etanercept levels between responders and non-responders in patients with ankylosing spondylitis treated with 25 mg etanercept twice a week
    de Vries, M. K.
    Wolbink, G. J.
    Nurmohamed, M. T.
    Aarden, L. A.
    Stapel, S. O.
    Peters, M. J. L.
    van denderen, J. C.
    Dijkmans, B. A. C.
    van der Horst-Bruinsma, I. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 395 - 395
  • [25] Assessment of patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept for up to 160 weeks.
    Dijkmans, Benjamin A. C.
    Sieper, Joachim
    van der Linden, Sjef
    Sibilia, Jean
    Mola, Emilio Martin
    Leirisalo-Repo, Marjatta
    Pedersen, Ronald
    Singh, Amitabh
    Freundlich, Bruce
    MacPeek, David
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S725 - S725
  • [26] Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial
    van der Heijde, Desiree
    Braun, Jurgen
    Dougados, Maxime
    Sieper, Joachim
    Pedersen, Ronald
    Szumski, Annette
    Koenig, Andrew S.
    RHEUMATOLOGY, 2012, 51 (10) : 1894 - 1905
  • [27] Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-TNF agents infliximab and etanercept
    Braun, J
    Baraliakos, X
    Listing, J
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 64 - 64
  • [28] Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system
    Azevedo, Valderilio Feijo
    Rossetto, Chayanne N.
    Lorencetti, Pedro G.
    Tramontin, Mariana Y.
    Fornazari, Bruna
    Araujo, Denizar V.
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2016, 56 (02) : 131 - 137
  • [29] Clinical response to long-term therapy with infliximab in patients with ankylosing spondylitis -: Results after 3 years.
    Baraliakos, X
    Brandt, J
    Listing, J
    Rudwaleit, M
    Alten, R
    Burmester, A
    Gromnicalhle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S217 - S217
  • [30] Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
    J. Braun
    H. Haibel
    M. de Hooge
    R. Landewé
    M. Rudwaleit
    T. Fox
    A. Readie
    H. B. Richards
    B. Porter
    R. Martin
    D. Poddubnyy
    J. Sieper
    D. van der Heijde
    Arthritis Research & Therapy, 21
12345